Fewer UC patients taking infliximab need surgery, study says

05/6/2013 | Healio

Treating severe ulcerative colitis with infliximab may reduce the likelihood patients will need a colon resection, researchers reported at a surgical conference. About 20% of UC patients generally need surgery, but researchers said the number was significantly reduced among those taking infliximab. Some 4.1% to 11.1% of treated patients underwent surgery, compared with 46.6% to 55.7% of untreated patients.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY